Home › Funds › Nextech Invest Ltd. › ZYME
Nextech Invest Ltd. position in ZYME
ZYMEWORKS INC · Health Care
Nextech Invest Ltd. reported holding 1,113,946 shares of ZYME (ZYMEWORKS INC) in its Q2 2026 13F filing — a position valued at US$29.1M, representing 1.38% of its reported portfolio and ranking #8 among its reported holdings. Nextech Invest Ltd. has disclosed ZYME holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s ZYME position evolved
Nextech Invest Ltd. first disclosed a stake in ZYME in Q1 2025 at 1,113,946 shares (US$13.3M). The position peaked in Q4 2025 at 1,113,946 shares, worth US$29.3M. Across 6 filings, Nextech Invest Ltd. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,113,946 shares valued at US$29.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.11M | $13.27M | New |
| Q2 2025 | 1.11M | $13.98M | Hold |
| Q3 2025 | 1.11M | $19.03M | Hold |
| Q4 2025 | 1.11M | $29.33M | Hold |
| Q1 2026 | 1.11M | $27.89M | Hold |
| Q2 2026 | 1.11M | $29.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 30 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- EcoR1 Capital, LLC 22.97M sh · $600.45M · Q2 2026
- Rubric Capital Management LP 7.00M sh · $182.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.18M sh · $109.34M · Q2 2026
- BVF INC/IL 3.65M sh · $95.39M · Q2 2026
- Prosight Management, LP 674.43K sh · $17.63M · Q2 2026
- Redmile Group, LLC 491.65K sh · $12.85M · Q2 2026
- Capricorn Fund Managers Ltd 486.53K sh · $12.72M · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held ZYME?
Nextech Invest Ltd. has disclosed ZYME holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Nextech Invest Ltd.'s current position in ZYME?
As of Q2 2026, Nextech Invest Ltd. holds 1.11M shares of ZYME (ZYMEWORKS INC), valued at $29.12M, representing 1.38% of its reported portfolio and ranking #8.
Has Nextech Invest Ltd. been buying or selling ZYME?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in ZYME. The position peaked in Q4 2025 at 1.11M shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.